1. Tsai CY, et al. The current status of visual disability in the elderly population of Taiwan. Jpn J Ophthalmol. 2005;49(2):166-172.

 2. Age-related macular degeneration (AMD). NHS.2021. Available from: https://www.nhs.uk/conditions/age-related-macular-degeneration-amd/

 3. 老年黃斑病變. 香港中文大學眼科及視覺科學學系. 2021. Available from: https://www.ovs.cuhk.edu.hk/zh/眼病小字典/老年黃斑病變病理和治療/.

 4. Iu LP, Kwok AK. An update of treatment options for neovascular age-related macular degeneration. Hong Kong Med J. 2007 Dec;13(6):460-70.

 5. Macular degeneration treatments – AMDF. American Macular Degeneration Foundation. 2022. Available from: https://www.macular.org/care-and-treatment/treatments.

 6. Mueller SB, Kontos CD. Tie1: An orphan receptor provides context for angiopoietin-2/tie2 signaling. J Clin Invest. 2016 Sep 1;126(9):3188-91.

 7. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006 Dec;27(12):552-8.

 8. Hobbs SD, Pierce K. Wet Age-related Macular Degeneration (Wet AMD). National Library of Medicine. StatPearls; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572147/.

 9. Age-related macular degeneration. The American Society of Retina Specialists. Available from: https://www.asrs.org/patients/age-related-macular-degeneration.

10. Wet macular degeneration. Mayo Clinic. Mayo Foundation for Medical Education and Research; 2020. Available from:https://www.mayoclinic.org/zh-hans/diseases-conditions/wet-macular-degeneration/symptoms-causes/syc-20351107.

11. Fluorescein Angiography. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.org/Fluorescein_Angiography.

12. Intravitreal Injections Patients The American Society of Retina Specialists. Available from: https://www.asrs.org/patients/retinal-diseases/33/intravitreal-injections.

13. Ranibizumab intravitreal injection (Rx). Medscape.2022. Available from: https://reference.medscape.com/drug/lucentis-byooviz-ranibizumab-intravitreal-injection-343645.

14. Aflibercept intravitreal (Rx). Medscape. 2023. Available from: https://reference.medscape.com/drug/eylea-aflibercept-intravitreal-999705.

15. Brolucizumab intravitreal (Rx). 2022. Available from: https://reference.medscape.com/drug/beovu-brolucizumab-intravitreal-1000350.

16. Moorfields Eye Hospital. Patient Information. Anti-VEGF intravitreal injection treatment – NHS. Available from:https://www.moorfields.nhs.uk/sites/default/files/uploads/documents/Patient%20information%20-%20intravitreal%20injections%20for%20AMD.pdf.

17. Faricimab. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.aao.org/Faricimab.

18. Nicolò M, et al. Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. Expert Opin Investig Drugs. 2021 Mar;30(3):193-200.

19. Vabysmo. Summary of Product Characteristics.

20. Photodynamic therapy (PDT). EyeWiki. American Academy of Ophthalmology; 2017. Available from: https://eyewiki.aao.org/Photodynamic_Therapy_(PDT).

21. Photodynamic therapy for age-related macular degeneration. Photodynamic Therapy for Age-Related Macular Degeneration. Johns Hopkins Medicine; 2021. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/photodynamic-therapy-for-agerelated-macular-degeneration.

22. Photodynamic Therapy: What You Can Expect. Kellogg Eye Center. 2016. Available from: https://www.med.umich.edu/1libr/Ophthalmology/OcularOncology/PhotodynamicTherapy-nonCancer.pdf.

23. Laser Photocoagulation for Age-Related Macular Degeneration . Johns Hopkins Medicine. 2021. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/laser-photocoagulation-for-agerelated-macular-degeneration.

24. Panretinal Photocoagulation Laser (PRP). NHS choices. NHS; 2019. Available from: https://www.hey.nhs.uk/patient-leaflet/panretinal-photocoagulation-laser-prp/.

25. Lin KD,et al. Diabetes-related kidney, eye, and foot disease in Taiwan: An analysis of nationwide data from 2005 to 2014,Journal of the Formosan Medical Association,Volume 118, Supplement 2,2019, Pages S103-S110.

26. Musat O. Diabetic Macular Edema. Romanian Journal of Pohthalmology. 2015;59(3):133–6.

27. Ciulla TA, et al. Diabetic retinopathy and diabetic macular edema. Diabetes Care. 2003;26(9):2653–64.

28. Sahni J, et al. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. Ophthalmology. 2019 Aug;126(8):1155-1170.

29. Diep TM, Tsui I. Risk factors associated with diabetic macular edema. Diabetes Research and Clinical Practice. 2013Jun;100(3):298–305.

30. Acan D, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018 Apr 12;18(1):91.

31. Overview -Diabetic retinopathy. NHS choices. NHS; 2021. Available from: https://www.nhs.uk/conditions/diabetic-retinopathy/.

32. Diabetic Macular Edema. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.org/Diabetic_Macular_Edema.

33. Patient Information. Laser treatment for diabetic macular oedema. Moorfields Eye Hospital. 2013. Available from: https://www.moorfields.nhs.uk/sites/default/files/uploads/documents/Patient%20information%20-%20laser%20for%20diabetic%20macula%20oedema.pdf.

34. Intravitreal Injections. Hull University Teaching Hospitals NHS Trust. 2021. Available from: https://www.hey.nhs.uk/patient-leaflet/intravitreal-injections/

35. Retinal Photodynamic Therapy (PDT). Hull University Teaching Hospitals NHS Trust. 2019. Available from: https://www.hey.nhs.uk/patient-leaflet/retinal-photodynamic-therapy-pdt/.